tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Mitsubishi UFJ Financial Group Increases Stake in Australian Clinical Labs

Story Highlights
  • Mitsubishi UFJ Financial Group increases its voting power in Australian Clinical Labs.
  • The change in shareholding may impact the company’s governance and market position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Mitsubishi UFJ Financial Group Increases Stake in Australian Clinical Labs

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Australian Clinical Labs Ltd ( (AU:ACL) ) has shared an update.

Australian Clinical Labs Ltd has announced a change in the substantial holding of its shares, with Mitsubishi UFJ Financial Group, Inc. increasing its voting power from 5.01% to 6.08%. This change in shareholding could impact the company’s governance and strategic decisions, potentially influencing its market position and stakeholder interests.

The most recent analyst rating on (AU:ACL) stock is a Buy with a A$4.25 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.

More about Australian Clinical Labs Ltd

Average Trading Volume: 922,127

Technical Sentiment Signal: Sell

Current Market Cap: A$538.1M

For a thorough assessment of ACL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1